Cresp Injection

Cresp Injection

Product Details:


Product Description

We have carved a niche by offering our clients superior quality Cresp that is world's first and India's only generic version of darbepoetin alpha. Offered medicine is used for the treatment of anemia caused by the renal transplants and other HIV conditions. Precisely formulated as per medical industry norms using quality-approved basic chemicals, this medicine is available with us in several packaging options to meet the diverse demands of the clients. Clients can avail this Cresp at market leading prices from us within committed time frame.


  • Precise composition

  • Accurate pH value

  • Purity

  • High effectiveness

We trade, supply, distribute and export Cresp to our esteemed clients. It is world's first and India's only generic version of darbepoetin alpha. It is used to treat anemia (from renal transplants or certain HIV treatment). Cresp helps in reduced frequency of doses providing a convenient treatment option for physicians and patients. It is highly effective and hence is widely appreciated by clients in domestic and international markets. It is available at highly reasonable prices in the market.

Cresp (darbepoetin alfa) injection is a physician endorsed medicate used to treat paleness because of perpetual kidney infection or because of chemotherapy. Cresp 40mcg infusion is an erythropoiesis-empowering operator (esa). It stimulates bone marrow to create more red platelets.

Producer : dr reddy's laboratories ltd.

Additional information :

  • Dosage available : 25mcg, 40mcg, 60mcg, 100mcg and 200mcg
  • Storage : store at temperature between 2oC - 8oC

Dosages :

  • Renal anemia: hemodialysis patients :
    • The standard dosage of cresp in grown-up patients is 20 μg as cresp (genetical recombination), to be regulated as a solitary intravenous infusion once week after week.
  • Peritoneal dialysis patients and patients with chronic kidney disease not on dialysis:
    • The standard dosage of cresp in grown-up patients is 30 μg as cresp (genetical recombination), to be controlled as a solitary infusion once like clockwork subcutaneously or intravenously.
  • Treatment of anemia in cancer patients receiving myelosuppressive chemotherapy:
    • Start cresp in patients on disease chemotherapy just if the hemoglobin is under 10 g/dl, and if there is at least two extra long stretches of arranged chemotherapy.

Reactions :

  • Basic indications are increased circulatory strain, hypersensitivity.
  • Pack size : pack of 1 vial


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

"We mainly export our products to the foreign countries."
Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.